ISMRM & ISMRT Annual Meeting & Exhibition • 10-15 May 2025 • Honolulu, Hawai'i

ISMRM & ISMRT 2025 Annual Meeting & Exhibition

Digital Poster

Preclinical Cancer: Head & Neck

Navigation: Back to Meeting HomeBack to Meeting Home Navigation: Back to Program-at-a-GlanceBack to the Program-at-a-Glance

Preclinical Cancer: Head & Neck
Digital Poster
Preclinical
Monday, 12 May 2025
Exhibition Hall
14:45 -  15:45
Session Number: D-209
No CME/CE Credit

 
Computer Number: 113
1929. GABA production induced by imipridones is a targetable and imageable metabolic alteration in diffuse midline gliomas
G. Batsios, S. Udutha, C. Taglang, A. M. Gillespie, B. Lau, S. Ji, T. Phoenix, S. Mueller, S. Venneti, C. Koschmann, P. Viswanath
University of Caifornia, San Francisco, San Francisco, United States
Impact: We have developed an integrated metabolic therapy and 1H-MRS-based imaging strategy for diffuse midline glioma patients. Clinical translation of our studies has the potential to enable precision metabolic therapy and imaging for children battling this devastating form of brain cancer.
 
Computer Number: 114
1930. Repeatability of quantitative MRI protocol of hypoxia, cellularity, and perfusion for habitat imaging in a murine glioma model
A. Das, D. Hormuth II, J. Virostko, T. Yankeelov
University of Texas at Austin, Austin, United States
Impact: We have presented updated findings on the repeatability of our quantitative and multiparametric MRI protocol for identifying tumor habitats. Our image-derived quantification of hypoxia, cellularity, and perfusion can capture tumor heterogeneity at the ROI level.
 
Computer Number: 115
1931. T1ρ as a biomarker for IDH1 mutation status in a glioma mouse model
H. Ehler, S. Sultana, C. Davis, K. Brewer, J. Rioux
Dalhousie University, Halifax, Canada
Impact: T1ρ quantitative imaging shows promise as a noninvasive biomarker to determine IDH1 mutation status in glioma. Such a biomarker would allow faster classification, eliminating the wait time for biopsy results and potentially improving patient outcome through more personalized treatment.
 
Computer Number: 116
1932. MRI Radiomics Reveals Sex Differences in a Preclinical Model of Glioblastoma Immunotherapy Response
V. Riberdy, A. Guida, J. Rioux, K. Brewer
Dalhousie University, Halifax, Canada
Impact: Understanding the role of sex-based variations in therapy response may lead to more effective treatment monitoring or personalized treatment plans for glioblastoma and other deadly cancers, ultimately increasing the clinical relevance and uptake of immunotherapies.  
 
Computer Number: 117
1933. Glioma Glycolysis, and Informed PET Interpretation: Metabolic Activity Diffusion Imaging (MADI) Tissue Cell Density
J. Schlegel, E. Baker, S. Holland, J. Stoller, W. Packwood, X. Li, R. Barajas, Jr., C. Springer, Jr., M. Pike
Oregon Health & Science University, Portland, United States
Impact: MADI is compatible with any MRI instrument, and shows promise for improved tumor detection, improved metabolic insights, and informing interpretation of other modality biomarkers.  MADI mapping investigations can lead to deeper insights into in vivo pathology metabolism. 
 
Computer Number: 118
1934. Multimodal imaging to assess treatment effect of a new therapy for glioblastoma in vivo
M. Al-Gizawiy, R. Wujek, K. Johnson, J. Sidabras, M. Prah, J. Connelly, C. Chitambar, K. Schmainda
Medical College of Wisconsin, Milwaukee, United States
Impact: Our work seeks to shift current research and clinical practice paradigms by utilizing a novel and innovative therapeutic approach to target the iron metabolism of aggressive primary brain tumors for patients with limited treatment options.
 
Computer Number: 119
1935. In Vivo Imaging of Xenon Biosensors using Hyperpolarized 129Xe MRI
M. Zhang, H. Li, H. Li, X. Zhao, Q. Zeng, W. Jiang, Y. Yuan, X. Liu, Y. Zheng, S. Yue, Q. Guo, Y. Han, X. Lou, L-S Bouchard, X. Zhou
Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences-Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan, China
Impact: Our findings advance molecular MRI technology by improving understanding of xenon biosensor distribution and dynamics. This approach lays the groundwork for future clinical applications of hyperpolarized xenon biosensors.
 
Computer Number: 120
1936. Prediction based on CE-T1WI imaging omics and pathological parameter models research on postoperative recurrence of glioma.
Y. Jin, X. Wang, G. Han
NINGXIA MEDICAL UNIVERSITY, Ningxia,China, China
Impact: The established radiomics and pathological parameter model demonstrate superior performance, encompassing dimensions from cellular to imaging levels, thereby providing more comprehensive information. These models hold substantial potential as pivotal tools for accurately predicting glioma recurrence, thereby enhancing prognostic accuracy.
 
Computer Number: 121
1937. Quantifying longitudinal changes in tumor habitats during radiotherapy via multiparametric MRI in a murine glioma model: Preliminary results
A. Das, D. Hormuth II, J. Virostko, T. Yankeelov
University of Texas at Austin, Austin, United States
Impact: Spatial and temporal changes in the tumor microenvironment impact treatment efficacy. Our multi parametric, quantitative MRI protocol effectively captured shifts in tumor composition during radiotherapy, offering valuable insights to improve outcomes.
 
Computer Number: 122
1938. Quantification of the engraftment status of mesenchymal stem cells in glioma using dual-modality MRI and BLI
Y. Li, Y. Tang, M. Cao, J. Shen
Sun Yat-Sen University, Sun Yat-Sen Memorial Hospital, Guangzhou, China
Impact: FTH and FLUC reporter genes-based MRI and BLI are practical tools for noninvasively monitoring the engraftment of MSCs in vivo. Peritumoral delivery of FTH-FLUC-MSCs offers robust engraftment and could be used as the optimal delivery route for treating malignant glioma.
 
Computer Number: 123
1939. Multimodal imaging reveals gliomas are cooler than normal tissue
D. Coman, P. Herman, J. Rao, J. Mihailovic, Y. Huang, G. Kaneko, F. Hyder
Yale University, New Haven, United States
Impact:

Temperature regulates the immune response, and thermal- and immuno-therapy might be combined for improved outcome. While temperature is rarely included into discussions related to tumor microenvironment, our results potentially impact future therapeutic directions because cooler conditions enhance tumor growth.

 
Computer Number: 124
1940. Parameters from novel non-Gaussian diffusion models for identifying the expression levels of prognostic factors in nasopharyngeal carcinoma
H. Ren, J. Zhang, D. Liu, J. Yang, J. Huang, Y. Huang, X. Ren, H. Yu, Y. Tan, l. Nie
Chongqing University Cancer Hospital, Chongqing, China
Impact: Non-Gaussian diffusion parameters can non-invasively assess prognostic factors in NPC and help doctors better manage NPC patients.
   
Computer Number: 125
1941. Near-infrared fluorescence imaging with a MET-targeting probe for biopsy site selection in patients with oral potentially malignant disorders
J. Wang, Q. Ma, Y. Yuan, X. Tao
Shanghai JiaoTong University, Shanghai, China
Impact: This study highlights NIRFI-assisted biopsy as a promising tool for enhancing early detection in oral cancer risk. By improving diagnostic precision in OPMDs, it opens avenues for research into broader applications of NIRFI in other head and neck cancers.
 
 
 
 
 
 
 
 
 
 
 
 
Computer Number: 126
1942. Radical-Free Hyperpolarized α-Ketoglutarate: Non-persistent radicals for Dissolution DNP
A. Gaunt, J. Lewis, W. Byrne, Y. Kim, X. Ji, D. Vigneron, A. Comment, J. Gordon
GE Healthcare, San Francisco, United States
Impact: HP photo-irradiated 13C-αKG can provide valuable metabolic information for assessing low-grade glioma1, potentially leading to improved diagnostic and treatment evaluation methods.
   
Computer Number:
1943. WITHDRAWN
Similar Session(s)

Navigation: Back to Meeting HomeBack to Meeting Home Navigation: Back to Program-at-a-GlanceBack to the Program-at-a-Glance

The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.